There are certainly some positives in this announcement.
It's just a shame it has taken all of this upheaval to see this type of change.
I applaud the Board's decision to accept remuneration via equity vs cash at this point in time.
Broad based macro risk off is the next challenge in seeing risk capital come back in to the small cap end of town.
Ann: Medibio announces board changes and cost reduction plans, page-3
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
